AUTL Autolus Therapeutics Ltd

USD 4.47 +0.03 ( +0.68)%
Icon

Autolus Therapeutics Ltd (AUTL) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 4.47

+0.03 (+0.68)%

USD 1.19B

0.41M

USD 9.00(+101.34%)

N/A

Icon

AUTL

Autolus Therapeutics Ltd (USD)
COMMON STOCK | NSD
USD 4.47
+0.03 ( +0.68)%

ETFs Holding Autolus Therapeutics Ltd (AUTL)

Symbol Name Exchange AUTL's Weight Expense Ratio Price(Change) Market Cap
CNCR
Loncar Cancer Immunothera.. NSD 1.56 % 0.79 % -0.33 (-2.17%) USD0.01B

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...